The goal is no longer a lower average. It is Time-in-Range — the share of the day your glucose stays where it should. We instrument it, read it, and act on it.
288 readings instead of one. The shaded band is the 70–180 mg/dL target. Everything above is hyperglycemia; everything below, a hidden low. This is one illustrative 24-hour trace.
Every 1% lift in Time-in-Range is roughly correlated with meaningful long-term risk reduction. We track it weekly — and show patients the curve, not just the verdict.
The pre-breakfast rise driven by overnight hormones. We catch it and re-time medication to meet it.
Which specific carbohydrate spikes you — pinpointed per meal, not guessed from a food diary.
When insulin or an oral agent fires too early or too late for your body's actual curve.
Insights from the AiHealth metabolic research program — thousands of patients and millions of continuous-glucose readings. This is what shapes the advice you get.
Insights from our continuous-glucose research program. See the science →
The Metabolic Intelligence Quotient folds glucose, variability, labs, body composition and adherence into a single 0–100 score — calibrated so a clinician can triage and a patient can track.
Intensive metabolic intervention, precision nutrition and GLP-1 / GIP integration aimed at clinical remission — or the tightest sustainable control where remission isn't possible.
Doctor-in-the-loop optimisation: basal rates, bolus ratios and hybrid closed-loop pump + CGM integration to minimise burden.
Early detection and aggressive metabolic correction to prevent progression — protecting maternal, fetal and long-term health.
A CGM goes on. Your continuous signal begins streaming into the platform from day one.
The pattern engine pre-analyses variability and events; MMIQ scores your baseline.
Dr. Bhograj reviews the read, approves the plan, and adjusts in real time — not in three months.
or message the AiHealth agent, any time.